PARSABIV sol inj 2.5 mg/0.5ml 6 flac 0.5 ml
7680663380010
CH-66338
H05BX04
07.05.0.
Reimbursement limitations:
PARSABIV
Pour la thérapie de l'hyperparathyroïdisme secondaire chez les patients en hémodialyse avec une valeur de …
1 / 3
google
Details
- Product number
- 6633801
- CPT
- -
- Packaging group
- 6
- Unit
- Durchstechflasche(n)
- Composition
- etelcalcetidum 2.5 mg ut etelcalcetidi hydrochloridum, natrii chloridum, acidum succinicum, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 0.5 ml corresp. natrium 2 mg.
Articles (1)
Parsabiv 2.5 mg, Injektionslösung
Injektionslösung
6
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 118.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2018
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66338
- Drug name
- Parsabiv, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- H05BX04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/09/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 07.05.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PARSABIV sol inj 2.5 mg/0.5ml 6 flac 0.5 ml
- Description (DE)
- PARSABIV Inj Lös 2.5 mg/0.5ml 6 Durchstf 0.5 ml
- Market launch
- 27/09/2017
- Narcotic (BTM)
- No